Navigation Links
NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
Date:11/7/2008

FT. MYERS, Fla., Nov. 7 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Rodman & Renshaw 10th Annual Healthcare Conference being held from November 10-12, 2008 at the New York Palace Hotel in New York City. The conference will showcase over 350 small and microcap public life sciences and biotech companies. Gasparini and other senior executives of attending companies will make presentations to portfolio managers and analysts on their business strategy and outlook. One-on-one meetings with interested parties will also be arranged during the three-day conference.

NeoGenomics is scheduled to present on Monday, November 10th at 5:20 PM EST. A live audio webcast of the presentation can be accessed at http://www.wsw.com/webcast/rrshq14/ngnm.ob . A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at http://www.neogenomics.org at the time of the conference. The webcast will be available for three months.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org'/>"/>

SOURCE NeoGenomics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
2. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
3. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
4. NeoGenomics Schedules its Q2 2008 Earnings Release for July 31, 2008
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...e/ -- Dr. Mate Hidvegi, inventor of Avemar ferment... issued on November 17 by Biropharma Kft, discredi...lf-serving statements about its U.S. competitor Am... his office in Budapest, Hungary: ,, "The Biro...y to AveULTRA, www.aveultra.com , is misleading...
(Date:11/19/2009)...., Nov. 19 Arlington Medical Resou...ading driver of antibiotic selection in nosocomial...ainst gram-positive and gram-negative pathogens. D...comial pneumonia, surveyed European physicians rev...de appropriate coverage against common pathogens, ...
(Date:11/19/2009)...nthesis Companies Form International Gene Synthesi...n Risk Reduction ,Five Member Companies Represen... , (PRWEB) November 19, 20...esis companies today announced agreement that they... biosecurity in the gene synthesis industry. By s...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...uly 1 BioMarin,Pharmaceutical Inc. (Nasdaq and SW...h.D., Chief Medical Officer of BioMarin, will pres... Conference in New York City on,Wednesday, July 9,...cess a live audio webcast of the presentation,via ...p://www.BMRN.com . A,replay of the presentation wi...
... Ben Eynon Each Assume Vice President Roles at ...N, Texas, July 1 Molecular Imprints, Inc., the,ma...ms and solutions, today,announced that Ben Eynon a...These distinguished industry veterans are assuming...ness development for semiconductors, and,vice pres...
...lized Psychiatric Patient Evaluation for Clinical ...ug Development, HAMILTON, N.J., July 1 MedAvante...ent evaluation, announced today that it has,closed...nd Trevi Health,Ventures. MedAvante has developed ... the assessment of patients undergoing treatment i...
Other Biology Technology:BioMarin to Present at the Collins Stewart Growth Conference 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 4
(Date:11/22/2009)...have succeeded in producing the polymers used for ...han through the use of fossil fuel based chemicals...w for the production of environmentally conscious ...l Biotechnology and Bioengineering to mark the j...ules found in everyday life in the form of plastic...
(Date:11/22/2009)...terfly,s proboscis looks like a straw -- long, sle...ke a paper towel, according to Konstantin Kornev o...s of this piece of insect anatomy to make small pr... Kornev will present his work next week at the 62...,s (APS) Division of Fluid Dynamics will take plac...
(Date:11/21/2009)...ewswire / - KINAXO Biotechnologies GmbH announce... new investors in the company, Leifina and Conmit ... Schumacher has been elected as a new member of th... Axel Ullrich, Hellmut Kirchner, Manfred Ferber as...tain Partners, BioM, High-Tech Grnderfonds, the Ma...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3WHO Withdraws Notice of Concern for Mylans Matrix Unit 13730 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 3Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 1Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 2Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 3
...DGE, Mass.-MIT scientists have found a way to indu...t could one day serve as tiny engineered blood ves...ol the cells, development by growing them on a sur...rk was posted this month in an online issue of Adv...d one day be transplanted into tissues such as the...
...ON, Ill. --- Neurotransmitters have consequences. ...y life, giving us the ability to move, to talk, to...ters are getting it right and sending proper signa...lls. , Now a Northwestern University study repor...controls a neurotransmitter in the nematode C. ele...
...ILLE, Tenn. U.S. Courts have decreed that the fe...naging nuclear wastes that will ensure the safety ...s, a period that is 200 times the length of record...rtainty in Long-Term Planning Nuclear Waste Manag...om government, industry, academia and the environm...
Other Biology News:MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3Managing nuclear wastes for the millennia 2
VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cryopreservation Service from AbD Serotec
...mismatch repair minus strains of E. coli. Use of t...zed unmethylated strand (1), leading to high mutat...ystems as the GeneEditor and Altered Sites II Muta...e recA+, therefore inserts containing highly repet...
Biology Products: